A part of clone with ZNF143, UBR4, and SMARCC2 gained JAK2V617F, underwent mitotic recombination on chromosome 9p and propagated as ET clones; and another clone harboring the three mutations gained TP53R248W in ET phase and evolved into AML clones. Here, SMARCC2 is linked to essential thrombocythemia.